A Smartphone Nutrition Tool for Teenagers Having Cancer Treatment
Tests MybYte, a smartphone nutrition tool, in teenagers having cancer treatment.
Plain-language title generated from the registry record
Registry title: Development of a Digital Personalised Nutrition Tool for Adolescents Undergoing Cancer Treatment
Key facts
- Where
- Leuven, BelgiumSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 18 years old?
Source: NCT07865117, who can take part
Where in Belgium
- University Hospitals Leuven (UZ Leuven)Leuven, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- KU Leuven
- Trial code
- NCT07865117
- Record updated
- 8 October 2026
- Original description
This study aims to develop and test MybYte, a smartphone tool designed to support personalised nutrition for teenagers aged 12-18 undergoing cancer treatment. MybYte will ask short questions about eating, appetite and treatment-related symptoms and provide personalised nutrition advice developed by healthcare professionals. In Phase 1, around 15 teenagers will help co-design and refine the tool through interviews and feedback. In Phase 2, around 15 newly diagnosed teenagers will use MybYte for one week each month over six months, alongside routine assessments of nutrition, body composition, taste, energy needs and quality of life. The study will assess whether MybYte is acceptable, practical and helpful for teenagers receiving cancer treatment.Read full original descriptionShow less
Digital Innovation for Personalised Nutrition in Adolescent Oncology
This study aims to develop and test MybYte, a smartphone tool designed to support personalised nutrition for teenagers aged 12-18 undergoing cancer treatment. MybYte will ask short questions about eating, appetite and treatment-related symptoms and provide personalised nutrition advice developed by healthcare professionals. In Phase 1, around 15 teenagers will help co-design and refine the tool through interviews and feedback. In Phase 2, around 15 newly diagnosed teenagers will use MybYte for one week each month over six months, alongside routine assessments of nutrition, body composition, taste, energy needs and quality of life. The study will assess whether MybYte is acceptable, practical and helpful for teenagers receiving cancer treatment.
Inclusion: Written informed consent has been obtained from a parent/legal guardian; Written assent has been obtained from participants; Aged between 12 and 18 years at the time of enrolment; Ability to use a smartphone independently; Adequate cognitive capacity to participate in study procedures, as determined by the research team; Proficiency in Dutch; For Phase 1:; Currently receiving, or having previously received cancer treatment (including chemotherapy) at University Hospitals Leuven within the specified age range; For Phase 2:; New histological diagnosis of cancer; Enrolled into the study within 6 weeks of diagnosis; Currently receiving cancer treatment (including chemotherapy) at University Hospitals Leuven.
Exclusion: Currently on a palliative care trajectory; Medical instability or clinical condition deemed too unwell for participation, as determined by the treating clinician; Presence of cognitive, developmental, or neurological impairments that compromise the ability to provide informed consent or assent, or that impair \ independent use of a digital tool; Admitted to the intensive care unit during the enrollment period.